Latest News & Articles from JJP Biologics

JJP BIOLOGICS ANNOUNCES POSITIVE TOP-LINE PHASE I TRIAL RESULTS OF JJP-1212, ITS ANTI-CD89 ANTAGONIST
JJP BIOLOGICS ANNOUNCES POSITIVE TOP-LINE PHASE I TRIAL RESULTS OF JJP-1212, ITS ANTI-CD89 ANTAGONIST

January 7, 2026JJP Biologics, a clinical-stage biotechnology company that specializes in the development of innovative biologics, today announces positive top-line…

Latest Videos

Subscribe

Want to Stay Informed?
Get Our Latest Updates

Subscribe to receive our regular updates